Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Supriya Lifescience has informed that it enclosed the transcript of the Earnings call held on Monday, August 12, 2024 at 11.00 am IST to discuss operational and financial performance of the Company for the quarter ended June 30, 2024 (Q1 of FY 2024-25).
The above information is a part of company’s filings submitted to BSE.